Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD - AMENDMENT

26th Nov 2018 12:41

FORM 8.3

Amendment to Sales

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 12 October 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary NPV
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 11,327,331 1.44% 12,109,394 1.52%
(2) Cash-settled derivatives:
11,806,416 1.49% 10,331,900 1.30%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 10,521,600 1.32% 10,941,600 1.38%
TOTAL: 33,655,347 4.25% 33,382,894 4.20%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ADR Purchase 5,581 19.5066 USD
ADR Purchase 7,000 19.2848 USD
ADR Purchase 53,000 19.3989 USD
ADR Purchase 120,172 19.4481 USD
ADR Sale 5,581 19.5066 USD
ADR Sale 7,000 19.2848 USD
ADR Sale 30,172 19.4794 USD
ADR Sale 53,000 19.3989 USD
ADR Sale 90,000 19.4377 USD
Ordinary NPV Purchase 44 4,357.8409 JPY
Ordinary NPV Purchase 100 4,387.8000 JPY
Ordinary NPV Purchase 104 4,361.5000 JPY
Ordinary NPV Purchase 107 4,358.7943 JPY
Ordinary NPV Purchase 200 4,372.0500 JPY
Ordinary NPV Purchase 228 4,361.6359 JPY
Ordinary NPV Purchase 558 4,359.5627 JPY
Ordinary NPV Purchase 600 4,370.0000 JPY
Ordinary NPV Purchase 683 4,361.1040 JPY
Ordinary NPV Purchase 900 4,399.0000 JPY
Ordinary NPV Purchase 1,194 4,357.6448 JPY
Ordinary NPV Purchase 1,700 4,381.7647 JPY
Ordinary NPV Purchase 1,800 4,391.4444 JPY
Ordinary NPV Purchase 1,841 4,356.3025 JPY
Ordinary NPV Purchase 2,500 4,383.0000 JPY
Ordinary NPV Purchase 2,800 4,381.7142 JPY
Ordinary NPV Purchase 2,900 4,368.0689 JPY
Ordinary NPV Purchase 2,900 4,355.9310 JPY
Ordinary NPV Purchase 3,000 4,378.5166 JPY
Ordinary NPV Purchase 3,400 4,368.1470 JPY
Ordinary NPV Purchase 4,200 4,392.9666 JPY
Ordinary NPV Purchase 4,516 4,360.0642 JPY
Ordinary NPV Purchase 4,700 4,391.1404 JPY
Ordinary NPV Purchase 5,500 4,370.9454 JPY
Ordinary NPV Purchase 6,500 4,387.6769 JPY
Ordinary NPV Purchase 10,500 4,377.0381 JPY
Ordinary NPV Purchase 12,000 4,385.8833 JPY
Ordinary NPV Purchase 15,200 4,394.7368 JPY
Ordinary NPV Purchase 15,700 4,357.0983 JPY
Ordinary NPV Purchase 24,300 4,375.2592 JPY
Ordinary NPV Purchase 27,725 4,359.6598 JPY
Ordinary NPV Purchase 29,500 4,396.2033 JPY
Ordinary NPV Purchase 29,800 4,394.0000 JPY
Ordinary NPV Purchase 33,000 4,350.0000 JPY
Ordinary NPV Purchase 54,900 4,367.2586 JPY
Ordinary NPV Purchase 82,100 4,370.2229 JPY
Ordinary NPV Purchase 100,000 4,378.3870 JPY
Ordinary NPV Purchase 167,800 4,368.4839 JPY
Ordinary NPV Purchase 333,000 4,373.3219 JPY
Ordinary NPV Purchase 333,500 4,373.1454 JPY
Ordinary NPV Purchase 385,800 4,371.0489 JPY
Ordinary NPV Sale 100 4,387.8000 JPY
Ordinary NPV Sale 200 4,372.0500 JPY
Ordinary NPV Sale 300 4,399.1666 JPY
Ordinary NPV Sale 400 4,359.0000 JPY
Ordinary NPV Sale 500 4,396.3000 JPY
Ordinary NPV Sale 1,200 4,383.5000 JPY
Ordinary NPV Sale 1,300 4,384.9692 JPY
Ordinary NPV Sale 1,700 4,381.7647 JPY
Ordinary NPV Sale 2,100 4,395.2857 JPY
Ordinary NPV Sale 2,300 4,378.5434 JPY
Ordinary NPV Sale 2,500 4,383.0000 JPY
Ordinary NPV Sale 2,900 4,368.0689 JPY
Ordinary NPV Sale 2,900 4,355.9310 JPY
Ordinary NPV Sale 3,400 4,370.1470 JPY
Ordinary NPV Sale 4,000 4,367.0000 JPY
Ordinary NPV Sale 4,100 4,390.7073 JPY
Ordinary NPV Sale 4,800 4,383.3645 JPY
Ordinary NPV Sale 5,900 4,387.2355 JPY
Ordinary NPV Sale 5,900 4,395.3389 JPY
Ordinary NPV Sale 6,700 4,393.7014 JPY
Ordinary NPV Sale 8,900 4,392.0022 JPY
Ordinary NPV Sale 9,600 4,366.7916 JPY
Ordinary NPV Sale 10,100 4,389.2673 JPY
Ordinary NPV Sale 17,800 4,372.5000 JPY
Ordinary NPV Sale 23,700 4,371.3122 JPY
Ordinary NPV Sale 30,100 4,385.1096 JPY
Ordinary NPV Sale 30,400 4,394.0000 JPY
Ordinary NPV Sale 48,000 4,625.0000 JPY
Ordinary NPV Sale 54,900 4,366.6612 JPY
Ordinary NPV Sale 168,400 4,368.5036 JPY
Ordinary NPV Sale 333,100 4,373.1624 JPY
Ordinary NPV Sale 366,000 4,371.2191 JPY
Ordinary NPV Sale 740,500 4,370.2908 JPY

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
Ordinary NPV SWAP Long 600 4,394.0000 JPY
Ordinary NPV CFD Long 24,500 4,366.5633 JPY
Ordinary NPV SWAP Short 44 4,357.8448 JPY
Ordinary NPV SWAP Short 104 4,361.5032 JPY
Ordinary NPV SWAP Short 107 4,358.7956 JPY
Ordinary NPV SWAP Short 228 4,361.6378 JPY
Ordinary NPV SWAP Short 558 4,359.5644 JPY
Ordinary NPV SWAP Short 683 4,361.1055 JPY
Ordinary NPV SWAP Short 1,194 4,357.6457 JPY
Ordinary NPV SWAP Short 1,841 4,356.3033 JPY
Ordinary NPV SWAP Short 4,516 4,360.0644 JPY
Ordinary NPV SWAP Short 15,700 4,357.0983 JPY
Ordinary NPV SWAP Short 27,725 4,359.6598 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 26 Nov 2018
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
Ordinary NPV Call Options Purchased 39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 40,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 82,000 5264.7000 European 25 Oct 2018
Ordinary NPV Call Options Written -460,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Written -104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Call Options Written -78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Call Options Written -70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Purchased -39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Written 75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Put Options Written 78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Put Options Written 114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Purchased 10,000,000 4620.0372 European 6 Nov 2018
Ordinary NPV Call Options Written -10,000,000 4620.0372 European 6 Nov 2018
Ordinary NPV Put Options Purchased -10,000,000 4620.0372 European 6 Nov 2018
Ordinary NPV Put Options Written 10,000,000 4620.0372 European 6 Nov 2018

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181126005393/en/

Copyright Business Wire 2018


Related Shares:

Barclays
FTSE 100 Latest
Value8,718.75
Change-40.24